Researchers at the Ragon Institute have made a significant discovery about how antibodies can directly enhance the body's ...

A team of Ohio State researchers engineered a new antibody that could revolutionize influenza prevention through a nasal ...

BMS will co-develop and co-commercialize BioNTech’s bispecific antibody BNT327 for solid tumors in a deal worth up to $11.1B ...

Researchers at the Ragon Institute have made a significant discovery about how antibodies can directly enhance the body's ...

The results feed into an effort to identify to monoclonal antibody combinations that would prevent and possibly treat HIV ...

Here we report on the optimization of two FLT3 antibodies using recombinant antibody technology. Initially, we considered two different strategies for optimization of the Fc part: modifications of ...

A new study has shown that person-to-person variation in antibody immunity plays a key role in shaping which influenza (flu) ...

Two-Part Dose Escalation and Expansion Trial Will Evaluate Efficacy and Safety of BYON4228 Alone and in Combination with Pembrolizumab NIJMEGEN, The ...

Agenus, which has been going through a reorganization after the FDA put the brakes on the biotech's regulatory plan for its ...

Merck & Co. has posted phase 2 data on zilovertamab vedotin in lymphoma, providing more evidence of the narrow safety and ...

can still latch onto the virus even if a part of it changes, thanks to its many arms. By combining IgM’s “stickiness” with IgG’s precision, Xu said his lab engineered an antibody that ...

New research suggests that an antibody-drug conjugate may offer practice-changing, patient-friendly treatment of blastic ...